Market Cap 225.17B
Revenue (ttm) 46.79B
Net Income (ttm) 15.51B
EPS (ttm) N/A
PE Ratio 12.10
Forward PE 14.42
Profit Margin 33.14%
Debt to Equity Ratio 0.72
Volume 12,080,100
Avg Vol 14,858,326
Day's Range N/A - N/A
Shares Out 4.47B
Stochastic %K 93%
Beta 0.77
Analysts Sell
Price Target $47.98

Company Profile

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The c...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 45 44 44 88 88
Address:
Novo Alle 1, Bagsvaerd, Denmark
alwayzwong
alwayzwong Jul. 4 at 2:49 AM
$NVO holding for $1HUNDO
0 · Reply
Hooooooold
Hooooooold Jul. 3 at 1:37 PM
$NVO $LLY FOUNDAYO IS GAINING! As nvo investor im worried now! At this rate foundayo is going to overtake wegovy oral in 2086!
3 · Reply
clan
clan Jul. 3 at 1:13 PM
$MNKD 🇺🇲 Inhalable mealtime insulin! Who knew?!? 🚫💉 #inhalemyinsulin 😲🤯 #Afrezza For the good of all diabetic Mannkind $LLY $SPY $NVO 🇺🇲💪
0 · Reply
michele1208
michele1208 Jul. 3 at 7:29 AM
New Symphony prescription data for $NVO and $LLY • Oral Wegovy: 115,591 prescriptions in week 26 vs. 116,767 in week 25. This marks the second consecutive weekly decline, though prescriptions remain close to the all-time high of 119,227 reached in week 24. • Foundayo: 5,501 prescriptions vs. 5,167 the previous week, continuing its gradual growth. It's worth noting that Symphony does not include prescriptions filled through online pharmacies, telehealth platforms, or NovoCare. Novo recently said Oral Wegovy had surpassed 3 million U.S. prescriptions just five months after launch, while Symphony has captured about 2.0 million prescriptions over the same period.
1 · Reply
brodyflowers
brodyflowers Jul. 3 at 2:33 AM
0 · Reply
ospreyeye
ospreyeye Jul. 3 at 12:32 AM
$NVO >> Daily Chart >> Closed above the 300 SMA @ 49.74 This is the key 🔑 level to hold and turn into support If support holds the 400 SMA @ 55.72 = next target 🎯 Downside risk on a close back below the 300 SMA $SPY $XLV
0 · Reply
Cedenmo
Cedenmo Jul. 3 at 12:29 AM
$NVO damn, I should have sold BMY at $60+ and added more to other positions - NVO, KHC, PYPL, and now PFE since recent dip (although I already have plenty of PFE). I knew this would start running back up - way too cheap for the balance sheet and the GLP-1 assets; missed opportunities sub-$40 and finally bought some at $41. Still underweight though.
0 · Reply
Hooooooold
Hooooooold Jul. 2 at 9:29 PM
$NVO eu approval soon? Its rocket lambo moon time
0 · Reply
ETAlpha
ETAlpha Jul. 2 at 9:28 PM
AI and chips getting hammered today, but money is rotating into safe havens. Healthcare and non-AI names are holding up strong. $NVO breaking over key $50 level and reclaiming its 200MA. $CELH up over 4%. Tech is lagging, but defensive value setups are working. Keeping it simple and adapting.
0 · Reply
Hooooooold
Hooooooold Jul. 2 at 8:54 PM
$NVO ganggggg
0 · Reply
Latest News on NVO
Better Buy in the Obesity Drug Race: Novo Nordisk or Eli Lilly?

Fri, 26 Jun 2026 16:47:53 -0400 - 7 days ago

Better Buy in the Obesity Drug Race: Novo Nordisk or Eli Lilly?


Swiss pharma at risk of US trade investigation, industry body says

Fri, 26 Jun 2026 12:39:36 -0400 - 7 days ago

Swiss pharma at risk of US trade investigation, industry body says


GLP-1s linked to smell and taste impairment in diabetes patients

Fri, 26 Jun 2026 10:45:46 -0400 - 7 days ago

GLP-1s linked to smell and taste impairment in diabetes patients


Novo's top US exec wants more insurance coverage for weight-loss drugs

Thu, 25 Jun 2026 05:07:02 -0400 - 8 days ago

Novo's top US exec wants more insurance coverage for weight-loss drugs


From Injection to Pill

2026-06-24T22:18:39.000Z - 9 days ago

From Injection to Pill


Top Research Reports for Shell, Novo Nordisk & SAP

2026-06-24T20:25:00.000Z - 9 days ago

Top Research Reports for Shell, Novo Nordisk & SAP


Novo Nordisk upgraded to Buy from Hold at Nordea

2026-06-19T11:15:41.000Z - 14 days ago

Novo Nordisk upgraded to Buy from Hold at Nordea

NVO


NVO: Novo Nordisk Targets Chinese Market with Wegovy Filing

2026-06-17T17:56:32.000Z - 16 days ago

NVO: Novo Nordisk Targets Chinese Market with Wegovy Filing


Ozempic Linked To Lower Risk Of Violence In New Study

Wed, 17 Jun 2026 11:45:12 -0400 - 16 days ago

Ozempic Linked To Lower Risk Of Violence In New Study


Europe’s biggest pharma company Novo Nordisk ‘hacked’

2026-06-17T11:27:07.000Z - 16 days ago

Europe’s biggest pharma company Novo Nordisk ‘hacked’


Eli Lilly vs. Novo Nordisk: Better Obesity Drug Stock?

Tue, 16 Jun 2026 13:00:00 -0400 - 17 days ago

Eli Lilly vs. Novo Nordisk: Better Obesity Drug Stock?


Novo Nordisk to File Oral Wegovy in China

2026-06-16T10:07:12.000Z - 17 days ago

Novo Nordisk to File Oral Wegovy in China


Novo Nordisk Plans to Seek Approval for Wegovy in China

2026-06-16T09:11:23.000Z - 17 days ago

Novo Nordisk Plans to Seek Approval for Wegovy in China


How LLY Overtook NVO in GLP-1 Space & Offering LLY Options Trade

Mon, 15 Jun 2026 12:30:35 -0400 - 18 days ago

How LLY Overtook NVO in GLP-1 Space & Offering LLY Options Trade


The Next Phase Of The Obesity Drug Race

Sat, 13 Jun 2026 14:00:05 -0400 - 20 days ago

The Next Phase Of The Obesity Drug Race


Drugmakers race to find a place in the next wave of obesity drugs

Sat, 13 Jun 2026 08:00:01 -0400 - 20 days ago

Drugmakers race to find a place in the next wave of obesity drugs


Novo Nordisk hit by cyber incident, probes data breach

Jun 11, 2026, 11:45 AM EDT - 22 days ago

Novo Nordisk hit by cyber incident, probes data breach


Novo Nordisk's Wegovy Weight Loss Pill Approved in the U.K.

Jun 11, 2026, 11:42 AM EDT - 22 days ago

Novo Nordisk's Wegovy Weight Loss Pill Approved in the U.K.


Novo Nordisk A/S: IT Security incident at Novo Nordisk

Jun 11, 2026, 11:30 AM EDT - 22 days ago

Novo Nordisk A/S: IT Security incident at Novo Nordisk


Novo Nordisk reports Wegovy pill approved in UK

2026-06-11T15:12:47.000Z - 22 days ago

Novo Nordisk reports Wegovy pill approved in UK


UK health regulator approves Novo Nordisk's weight-loss pill

Jun 11, 2026, 11:01 AM EDT - 22 days ago

UK health regulator approves Novo Nordisk's weight-loss pill


Novo Nordisk CEO: We are a cardiometabolic powerhouse

Jun 9, 2026, 1:30 PM EDT - 24 days ago

Novo Nordisk CEO: We are a cardiometabolic powerhouse


Use of GLP-1 drugs early in pregnancy should not cause alarm

Jun 8, 2026, 5:05 PM EDT - 25 days ago

Use of GLP-1 drugs early in pregnancy should not cause alarm

LLY


The Wegovy pill is still dominating the GLP-1 pill market

Jun 7, 2026, 7:35 PM EDT - 26 days ago

The Wegovy pill is still dominating the GLP-1 pill market


Novo Nordisk Transcript: Investor update

Jun 7, 2026, 7:30 PM EDT - 26 days ago

Novo Nordisk Transcript: Investor update


Novo Nordisk Slides: Investor update

Jun 7, 2026, 7:30 PM EDT - 26 days ago

Novo Nordisk Slides: Investor update


Novo Nordisk launches Wegovy in UAE

Jun 3, 2026, 4:33 AM EDT - 4 weeks ago

Novo Nordisk launches Wegovy in UAE


Novo Nordisk Launches Wegovy Weight-Loss Pill in UAE

Jun 3, 2026, 3:03 AM EDT - 4 weeks ago

Novo Nordisk Launches Wegovy Weight-Loss Pill in UAE


European Regulator Backs Novo Nordisk's Wegovy Weight-Loss Pill

May 22, 2026, 8:30 AM EDT - 6 weeks ago

European Regulator Backs Novo Nordisk's Wegovy Weight-Loss Pill


Novo Nordisk's next obesity battlefront: Winning beyond America

May 18, 2026, 1:00 AM EDT - 6 weeks ago

Novo Nordisk's next obesity battlefront: Winning beyond America


alwayzwong
alwayzwong Jul. 4 at 2:49 AM
$NVO holding for $1HUNDO
0 · Reply
Hooooooold
Hooooooold Jul. 3 at 1:37 PM
$NVO $LLY FOUNDAYO IS GAINING! As nvo investor im worried now! At this rate foundayo is going to overtake wegovy oral in 2086!
3 · Reply
clan
clan Jul. 3 at 1:13 PM
$MNKD 🇺🇲 Inhalable mealtime insulin! Who knew?!? 🚫💉 #inhalemyinsulin 😲🤯 #Afrezza For the good of all diabetic Mannkind $LLY $SPY $NVO 🇺🇲💪
0 · Reply
michele1208
michele1208 Jul. 3 at 7:29 AM
New Symphony prescription data for $NVO and $LLY • Oral Wegovy: 115,591 prescriptions in week 26 vs. 116,767 in week 25. This marks the second consecutive weekly decline, though prescriptions remain close to the all-time high of 119,227 reached in week 24. • Foundayo: 5,501 prescriptions vs. 5,167 the previous week, continuing its gradual growth. It's worth noting that Symphony does not include prescriptions filled through online pharmacies, telehealth platforms, or NovoCare. Novo recently said Oral Wegovy had surpassed 3 million U.S. prescriptions just five months after launch, while Symphony has captured about 2.0 million prescriptions over the same period.
1 · Reply
brodyflowers
brodyflowers Jul. 3 at 2:33 AM
0 · Reply
ospreyeye
ospreyeye Jul. 3 at 12:32 AM
$NVO >> Daily Chart >> Closed above the 300 SMA @ 49.74 This is the key 🔑 level to hold and turn into support If support holds the 400 SMA @ 55.72 = next target 🎯 Downside risk on a close back below the 300 SMA $SPY $XLV
0 · Reply
Cedenmo
Cedenmo Jul. 3 at 12:29 AM
$NVO damn, I should have sold BMY at $60+ and added more to other positions - NVO, KHC, PYPL, and now PFE since recent dip (although I already have plenty of PFE). I knew this would start running back up - way too cheap for the balance sheet and the GLP-1 assets; missed opportunities sub-$40 and finally bought some at $41. Still underweight though.
0 · Reply
Hooooooold
Hooooooold Jul. 2 at 9:29 PM
$NVO eu approval soon? Its rocket lambo moon time
0 · Reply
ETAlpha
ETAlpha Jul. 2 at 9:28 PM
AI and chips getting hammered today, but money is rotating into safe havens. Healthcare and non-AI names are holding up strong. $NVO breaking over key $50 level and reclaiming its 200MA. $CELH up over 4%. Tech is lagging, but defensive value setups are working. Keeping it simple and adapting.
0 · Reply
Hooooooold
Hooooooold Jul. 2 at 8:54 PM
$NVO ganggggg
0 · Reply
Hooooooold
Hooooooold Jul. 2 at 8:39 PM
$NVO this winning feels great
0 · Reply
Skyhigh_69
Skyhigh_69 Jul. 2 at 8:34 PM
$NVO This is my next position. This goes to 100k. Watch me! $PFE
1 · Reply
Skyhigh_69
Skyhigh_69 Jul. 2 at 8:31 PM
0 · Reply
alwayzwong
alwayzwong Jul. 2 at 8:27 PM
1 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Jul. 2 at 8:15 PM
$NVO Both semaglutide (Novo Nordisk) and tirzepatide (Eli Lilly) have very similar side effect profiles. Because individual reactions vary, there is no definitive consensus on which has "fewer" side effects. However, gastrointestinal issues like nausea, vomiting, and diarrhea are common with both medications.Semaglutide is a single GLP-1 agonist, while tirzepatide works on two hormone receptors (GIP and GLP-1), allowing it to yield greater average weight loss. Because of this, some patients on Reddit report that tirzepatide actually causes fewer or less severe gastrointestinal side effects than semaglutide, while others experience the exact opposite.
0 · Reply
StockRadarr
StockRadarr Jul. 2 at 8:07 PM
$NVO sema usage at 40% vs $LLY TZP at 60% says a lot. Beyond self-pay, it gets even tougher for sema. If you split it out, 5 mg TZP looks stronger than full-dose sema, with fewer side effects. That’s where you start questioning why a primary doc or specialist would choose the weaker option.
1 · Reply
BluntForceOptions
BluntForceOptions Jul. 2 at 7:09 PM
$NVO R-1 price target secured.
1 · Reply
Maverickyo1
Maverickyo1 Jul. 2 at 6:49 PM
$NVO in Jan leaps from $37 idk man to me this thing has a ton to run still
1 · Reply
Maverickyo1
Maverickyo1 Jul. 2 at 6:48 PM
$NVO do my eyes deceive me? Is that 50. What the heck
0 · Reply
Jrunner20
Jrunner20 Jul. 2 at 6:46 PM
$NVO I’m out been in since 42. Good gain on my 2k shares. I’ll reload if we get mid 40s again.
0 · Reply
nhashan
nhashan Jul. 2 at 6:12 PM
$NVO Great action so far! I am aiming for 55 😊
0 · Reply
TTradeStation
TTradeStation Jul. 2 at 6:09 PM
$NVO the buy order above 50 and pathetic...algos pin at 49.90-50.10 at close
0 · Reply